Press release
Pulmonary Embolism Market in Depth Analysis, Global Trends, New Technologies, Regional Analysis, Growth Factors and Forecast 2029
Pulmonary Embolism Market
In recent years, the pulmonary embolism market is anticipated to grow rapidly during the forecast period. The global market for pulmonary embolism is primarily driven by an increase in the use of prevalence of pulmonary embolism diseases. In the elderly, pulmonary illnesses can be lethal. The rising prevalence of this health problem among the world's elderly population is expected to drive the pulmonary embolism market's sales in the coming years. Different technological breakthroughs are being incorporated into the healthcare industry in terms of diagnostics, healthcare, and medical treatment. This scenario favours the expansion of the pulmonary embolism market.
Data Bridge Market Research analyses that the pulmonary embolism market was valued at USD 1.65 billion in 2021 and is expected to reach USD 3.12 billion by 2029, registering a CAGR of 8.30% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Opportunities
Increase in the number of research and development activities
Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the pulmonary embolism market growth. Along with this, rising drug approvals and launches will further propel the market's growth rate.
Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the pulmonary embolism market growth during the forecast period.
Segmentation:
The pulmonary embolism market is segmented on the basis of symptoms, diagnosis, treatment, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Symptoms
Shortness of Breath
Chest Pain
Cough
Irregular Heartbeat
Dizziness
Fever
Cyanosis
Others
On the basis of symptoms, the pulmonary embolism market is segmented into shortness of breath, chest pain, cough, irregular heartbeat, dizziness, fever, cyanosis and others.
Diagnosis
Chest X-Ray
ECG
MRI
CT Scan
Pulmonary Angiography
Venography
Venous Ultrasound
D-Dimer Test
Others
On the basis of diagnosis, the pulmonary embolism market is segmented into chest X-Ray, ECG, MRI, CT scan, pulmonary angiography, venography, venous ultrasound, D-dimer test and others.
Treatment
Medications
Mechanical Devices
Surgery
Others
On the basis of treatment, the pulmonary embolism market is segmented into medications, mechanical devices, surgery and others. Treatment by medication includes anticoagulants, thrombolytics and others. Treatment by mechanical devices includes catheter, compression stockings and others. Surgical treatment includes clot removal, vein filter and others.
End-Users
Hospitals
Specialty Clinics
Homecare
Others
On the basis of end-users, the pulmonary embolism market is segmented into hospitals, specialty clinics, homecare and others.
Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
On the basis of distribution channel, the pulmonary embolism market has also been segmented into hospital pharmacy, retail pharmacy, online pharmacy and others.
Key Market Players:
Abbott (US)
Hoffmann-La Roche Ltd. (Switzerland)
Mylan N.V. (US)
Teva Pharmaceutical Industries Ltd.(Jerusalem)
Sanofi (France)
Pfizer Inc. (US)
GlaxoSmithKline plc (UK)
Bristol-Myers Squibb Company (U.S.)
Hikma Pharmaceuticals PLC (UK)
Johnson & Johnson Private Limited (US)
Novartis AG (Switzerland)
Boehringer Ingelheim International GmbH. (Germany)
Fresenius Kabi AG (Germany)
Bayer AG (Germany)
Eli Lilly and Company (US)
Merck & Co., Inc. (US)
Baxter (US)
AstraZeneca (UK)
Genentech Inc. (US)
Aspen Holdings (South Africa)
Attractions of The Pulmonary Embolism Market Report: -
Latest market dynamics, development trends and growth opportunities are presented along with industry barriers, developmental threats and risk factors
The forecast Pulmonary Embolism Market data will help in the feasibility analysis, market size estimation and development
The report serves as a complete guide which micro monitors all vital Pulmonary Embolism Market
A concise market view will provide ease of understanding.
Nut Oil Market Competitive market view will help the players in making a right move
Key Questions Answered
What impact does COVID-19 have made on Global Pulmonary Embolism Market Growth & Sizing?
Who are the Leading key players and what are their Key Business plans in the Global Pulmonary Embolism Market?
What are the key concerns of the five forces analysis of the Global Pulmonary Embolism Market?
What are different prospects and threats faced by the dealers in the Global Pulmonary Embolism Market?
What are the strengths and weaknesses of the key vendors?
Browse More Info @ https://www.databridgemarketresearch.com/reports/global-pulmonary-embolism-market
More Reports:
https://sagark18dbmr.blogspot.com/2023/05/cord-blood-banking-service-market.html
https://sagark18dbmr.blogspot.com/2023/05/johnson-neuroectodermal-syndrome-market.html
https://sagark18dbmr.blogspot.com/2023/05/autonomic-dysreflexia-treatment-market.html
https://sagark18dbmr.blogspot.com/2023/05/dual-chamber-prefilled-syringes-market.html
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email - corporatesales@databridgemarketresearch.com
About Us:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.
Data Bridge Market Research provides appropriate solutions to complex business challenges and initiates an effortless decision-making process.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pulmonary Embolism Market in Depth Analysis, Global Trends, New Technologies, Regional Analysis, Growth Factors and Forecast 2029 here
News-ID: 3064468 • Views: …
More Releases from DBMR
Feed Pigments Market - Industry Trends and Forecast
Global Feed Pigments Market, By Type (Carotenoids, Curcumin, Caramel, Spirulina and Others), Carotenoids Source (Natural and Synthetic), Livestock (Swine, Poultry, Ruminants, Aquatic Animals and Others) - Industry Trends and Forecast to 2029.
Feed Pigments Market Analysis and Size
Feed pigments are used to enhance the colour of products such as eggs, meat, and milk. The key drivers for this market are rising meat production demand, rising disposable incomes, a shift toward pellet…
Automatic Brewing Equipment Market - Industry Trends and Forecast
Global Automatic Brewing Equipment Market, By Brewery Type (Macrobrewery, Craft Brewery), Equipment Type (Macrobrewery Equipment, Craft Brewery Equipment), Material Type (Brass, CopperAluminumStainless steel, Mild steel) - Industry Trends and Forecast to 2029.
Automatic Brewing Equipment Market Analysis and Size
Beers provide antioxidants and are a low-calorie alternative to other drinks. Along with being appropriately rich in vitamin B, vitamin B3, and vitamin B6, it also gives our bodies with vital fibre content.…
Digestive Health Food and Drinks Market - Industry Trends and Forecast
Data Bridge Market Research analyses that the global digestive health food and drinks market to account USD 63.43 billion by 2029 growing at a CAGR of 7.85% in the forecast period of 2022-2029.
Digestive health drinks are products that help to counteract the effects of an overburdened digestive tract. Drinks, when consumed properly, can aid in the prevention of a variety of small and large intestine health problems. There are…
Activin A Market Size, Share, Growth, Trends and Forecast
Activin A market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 12.50% in the above mentioned forecast period.
Activin A is a member of the TGF-beta super family and shows structural similarities with TGF-beta 1. Activins are the disulphide linked dimeric proteins that causes stimulation of pituitary follicle stimulating hormone…
More Releases for Pulmonary
Chronic Pulmonary Aspergillosis Drugs Market - Revitalizing Lungs: Revolutionary …
Newark, New Castle, USA - new report, titled Chronic Pulmonary Aspergillosis Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Pulmonary Aspergillosis Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Pulmonary Aspergillosis Drugs market. The report offers…
Global Pulmonary Embolism Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Pulmonary Embolism Market is exhibited at USD 1.59 billion in 2023 and is projected to surpass USD 3.15 billion in 2028, anticipated to grow at a CAGR of 8.4% from 2023 to 2028.
The rapid increase in the prevalence of cancer, increasing investment for healthcare infrastructure and rising research and development activities, high disposable income, rising demand…
Global Pulmonary Arterial Hypertension Market Size
According to a new market research report published by Global Market Estimates, the Global Pulmonary Arterial Hypertension Market is projected to grow at a CAGR of 5.2% from 2022 to 2027.
Congenital heart diseases and other ailments such as HIV infection, chronic liver disease (cirrhosis), and connective tissue disorders (scleroderma, lupus, and others) are fueling market expansion.
Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC…
New Study: Pulmonary Drugs Market Report
The pulmonary drugs market is expected to witness unprecedented growth in the near future, thanks to large number of approvals from the FDA. The FDA approved a large number of pulmonary drugs for major illnesses like small-cell lung cancer, tuberculosis, and pneumonia over the past few years. Additionally, newly approved drugs also treat newly found diseases like obstructive sleep apnea. These approvals are in line with the recent trend of…
Pulmonary Drugs Market Forecast till 2025
Pulmonary Drugs Market – Boon for Diseased Lungs
Pulmonary drugs can treat wide range of conditions, which are included within the ambit of pulmonary diseases such as pneumonia, allergic rhinitis, pulmonary hypertension, and others. . Pulmonary drugs provide medications for all types of pulmonary diseases, which is expected to fuel market growth in near future. The World Health Organization (WHO) states that most respiratory diseases are preventable and can be treated…
Pulmonary Drug Delivery Devices Market: Demand for Pulmonary Drug Delivery Devic …
This report on pulmonary drug delivery devices studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pulmonary/respiratory drugs and/or drug-device combinations as well as new entrants planning to enter this market.
This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments…
